Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin.
Peng T, Wu JR, Tong LJ, Li MY, Chen F, Leng YX, Qu R, Han K, Su Y, Chen Y, Duan WH, Xie H, Ding J.
Peng T, et al.
Acta Pharmacol Sin. 2014 Jul;35(7):916-28. doi: 10.1038/aps.2014.33. Epub 2014 May 26.
Acta Pharmacol Sin. 2014.
PMID: 24858311
Free PMC article.